Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1990 1
2003 1
2005 2
2010 1
2011 3
2013 1
2014 1
2015 1
2017 1
2019 3
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B, Bonkovsky HL, Lim JK, Balwani M. Wang B, et al. Gastroenterology. 2023 Mar;164(3):484-491. doi: 10.1053/j.gastro.2022.11.034. Epub 2023 Jan 13. Gastroenterology. 2023. PMID: 36642627 Free PMC article. Review.
AHP is also associated with chronic symptoms and long-term risk of systemic arterial hypertension, chronic renal and liver disease, and hepatocellular carcinoma. Patients who have recurrent acute attacks (4 or more per year) should be considered for prophylactic …
AHP is also associated with chronic symptoms and long-term risk of systemic arterial hypertension, chronic renal and liver disease, a …
Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies.
Hamed SA. Hamed SA. Expert Rev Clin Pharmacol. 2019 Jan;12(1):61-90. doi: 10.1080/17512433.2019.1555468. Epub 2019 Jan 11. Expert Rev Clin Pharmacol. 2019. PMID: 30501441 Review.
They include (1) accumulation of uremic toxins resulting in neurotoxicity, blood-brain barrier injury, neuroinflammation, oxidative stress, apoptosis, brain neurotransmitters imbalance, ischemic/microvascular changes, and brain metabolism dysfunction (e.g. dopamine deficiency), ( …
They include (1) accumulation of uremic toxins resulting in neurotoxicity, blood-brain barrier injury, neuroinflammation, oxidative stress, …
Does fludrocortisone treatment cause hypomagnesemia in children with primary adrenal insufficiency?
Erbaş İM, Altincik SA, Çatli G, Ünüvar T, Özhan B, Abaci A, Anik A. Erbaş İM, et al. Turk J Med Sci. 2021 Feb 26;51(1):231-237. doi: 10.3906/sag-2008-167. Turk J Med Sci. 2021. PMID: 33155789 Free PMC article.
BACKGROUND/AIM: Aldosterone is a mineralocorticoid that secreted from adrenal glands and a known factor to increase magnesium excretion by direct and indirect effects on renal tubular cells. Although the frequency of hypomagnesemia was found to be approximately 5% i …
BACKGROUND/AIM: Aldosterone is a mineralocorticoid that secreted from adrenal glands and a known factor to increase magnesium excretion by d …
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer.
Knijnenburg SL, Mulder RL, Schouten-Van Meeteren AY, Bökenkamp A, Blufpand H, van Dulmen-den Broeder E, Veening MA, Kremer LC, Jaspers MW. Knijnenburg SL, et al. Cochrane Database Syst Rev. 2013 Oct 8;(10):CD008944. doi: 10.1002/14651858.CD008944.pub2. Cochrane Database Syst Rev. 2013. PMID: 24101439 Updated. Review.
However, evidence about the long-term effects of these treatments on renal function remains inconclusive. To reduce the number of (long-term) nephrotoxic events in CCS, it is important to know the risk of, and risk factors for, early and late renal adverse effects, …
However, evidence about the long-term effects of these treatments on renal function remains inconclusive. To reduce the number of (lo …
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans EC, Bökenkamp A, Tjahjadi NS, Tettero JM, van Dulmen-den Broeder E, van der Pal HJ, Veening MA. Kooijmans EC, et al. Cochrane Database Syst Rev. 2019 Mar 11;3(3):CD008944. doi: 10.1002/14651858.CD008944.pub3. Cochrane Database Syst Rev. 2019. PMID: 30855726 Free PMC article.
Risk of bias was present in all studies. AUTHORS' CONCLUSIONS: The prevalence of adverse renal effects after treatment with cisplatin, carboplatin, ifosfamide, radiation therapy involving the kidney region, nephrectomy, or any combination of these, ranged from 0% to …
Risk of bias was present in all studies. AUTHORS' CONCLUSIONS: The prevalence of adverse renal effects after treatment with cisplatin …
Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE).
Lip GYH, Coca A, Kahan T, Boriani G, Manolis AS, Olsen MH, Oto A, Potpara TS, Steffel J, Marín F, de Oliveira Figueiredo MJ, de Simone G, Tzou WS, En Chiang C, Williams B. Lip GYH, et al. Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):235-250. doi: 10.1093/ehjcvp/pvx019. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28541499 Review.
Hypertension (HTN) is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease (CAD), stroke, peripheral artery disease and chronic renal failure. Hypertensive heart disease can manifest as many types of cardiac arrhythmias, most commonly …
Hypertension (HTN) is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease (CAD), stroke, peripheral a …
Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood.
Faguer S, Decramer S, Chassaing N, Bellanné-Chantelot C, Calvas P, Beaufils S, Bessenay L, Lengelé JP, Dahan K, Ronco P, Devuyst O, Chauveau D. Faguer S, et al. Kidney Int. 2011 Oct;80(7):768-76. doi: 10.1038/ki.2011.225. Epub 2011 Jul 20. Kidney Int. 2011. PMID: 21775974 Free article.
Whole-gene deletion was found in 11 families, point mutations in 9, and de novo mutations in half of the kindred tested. Renal involvement was extremely heterogeneous, with a tubulointerstitial profile at presentation and slowly progressive renal decline throughout …
Whole-gene deletion was found in 11 families, point mutations in 9, and de novo mutations in half of the kindred tested. Renal involv …
Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer.
Ouwerkerk J, Boers-Doets C. Ouwerkerk J, et al. Eur J Oncol Nurs. 2010 Sep;14(4):337-49. doi: 10.1016/j.ejon.2010.03.004. Epub 2010 May 23. Eur J Oncol Nurs. 2010. PMID: 20580896 Review.
We reviewed the literature regarding the signs and symptoms, assessment of severity, and strategies available to prevent and manage adverse events associated with these agents. KEY RESULTS: This class of therapeutics is associated with an overall acceptable adverse event p …
We reviewed the literature regarding the signs and symptoms, assessment of severity, and strategies available to prevent and manage adverse …
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life.
Esteban-Fernández A, Ortiz Cortés C, López-Fernández S, Recio Mayoral A, Camacho Jurado FJ, Gómez Otero I, Molina M, Almenar Bonet L, López-Vilella R. Esteban-Fernández A, et al. ESC Heart Fail. 2022 Oct;9(5):3071-3078. doi: 10.1002/ehf2.13976. Epub 2022 Jun 24. ESC Heart Fail. 2022. PMID: 35748119 Free PMC article.
AIMS: Hyperkalaemia (HK) is common in heart failure (HF) patients, related to renal dysfunction and medical treatment. It limits medical therapy optimization, which impacts prognosis. ...There were no other electrolyte disturbances, with a slight improvement in r …
AIMS: Hyperkalaemia (HK) is common in heart failure (HF) patients, related to renal dysfunction and medical treatment. It limits medi …
19 results